Notably, lung cancer cells from clinical samples contained a significantly higher percentage of ALDH1A1+ cells that were resistant to epidermal growth factor receptor (EFGR) trypsin kinase inhibitor (TKI) and chemotherapy, manifesting one of the fundamental properties of CSCs [53]. This evidence concerns the gene ALDH1A1 and lung carcinoma.